MediLife

What MediLife does

MediLife is a London-headquartered MedTech commercialisation consultancy founded in 2016 by Ian Galloway, with a 2024-opened German office in Erlangen that serves as its EU base. The firm provides integrated clinical research, market access, commercial consultancy, and embedded sales team deployment services to help global MedTech and digital health companies enter and scale across UK and European markets spanning 25+ countries. Its service portfolio covers CRO functions (clinical study design, real-world evidence, KOL engagement, regulatory submissions), commercial strategy (NHS market access, go-to-market planning, reimbursement), and a hybrid channel model where MediLife-employed Key Account Managers directly represent client brands inside NHS trusts, private hospitals, and German GPOs. The company maintains a dedicated digital health sub-brand (MediLife Digital Health) anchored by Vera, a proprietary compliance intelligence platform that applies deterministic review to regulatory submissions for SaMD products. Through the 2023 co-founded YOUTILIX venture, MediLife extends into dedicated radiology AI commercialisation across DACH and the UK.

The business operates on a professional services revenue model, combining fixed-fee support packages for clinical trial setup, market entry, sales team implementation, and investor due diligence with bespoke enterprise consultancy engagements. Pricing is not publicly disclosed; engagements are scoped per client. Its customer base spans global MedTech innovators (NeoDynamics, AB-CT, Cairn Surgical, AIRS Medical, Promedius) and large pharmaceutical companies (Valneva, Tillotts Pharma, Menarini, Sobi, Takeda), with stated average partnership length exceeding three years. MediLife differentiates on parallel clinical-and-commercial execution, running CRO programmes and commercial operations simultaneously rather than sequentially, which it claims compresses time-to-market. The firm is privately held and founder-controlled, with no disclosed external investment, and holds ISO 9001:2015, UK GDPR, Cyber Essentials PLUS, and NHS DSPT certifications relevant to handling regulated health data.

Headcount sits at approximately 22 employees, with senior leadership (CEO Ian Galloway and CCO Paul Rowe) working directly on client engagements alongside functional heads in clinical/regulatory, sales/marketing, digital health software, and a German commercial team. Certifications, NHS-aligned data security clearances, and accumulated clinical network relationships function as regulatory and ecosystem moats, while the Vera platform represents an early move to productise internal expertise. Growth signals are concentrated in 2023-2024 geographic and vertical expansion, including the YOUTILIX radiology AI venture and German office buildout, indicating deliberate but measured scaling rather than venture-backed hyper-growth.

Name

MediLife

Legal name

MediLife

Website

https://medilife.net

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

MediLife is a London-based MedTech commercialisation consultancy, founded in 2016, that helps global medical device and pharma companies enter UK and European markets through integrated clinical research, commercial consultancy, and embedded sales team deployment across 25+ countries.

Ownership category

akta.pro rank

Product category

MedTech Commercialisation Services

NAICS

Public Relations Agencies (541820), Computer Systems Design and Related Services (54151), Software Publishers (513210)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Medtech market entry
• Clinical research services
• Commercial consultancy
• Regulatory compliance
• Sales team deployment

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical Research Services: CRO services including clinical study design and management, real-world evidence generation, KOL engagement and site selection, and regulatory submissions support.
2. Commercial Consultancy: Market entry strategy, go-to-market planning, NHS access, KOL engagement strategy, regulatory pathway support, and commercial execution advisory services.
3. Fixed-Fee Support Packages: Pre-defined packages for market entry, clinical trial setup, sales team implementation, and investor due diligence delivered as fixed-fee engagements.
4. Sales Team Deployment: Embedded commercial teams including sales managers, country managers, and marketing leads employed and managed by MediLife representing client brands.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

MediLife is a UK-based MedTech commercialisation consultancy that helps global medical device, digital health, and pharmaceutical companies enter and scale in UK and European markets. It delivers integrated clinical research, regulatory, commercial consultancy, marketing, and embedded sales team deployment services in parallel rather than sequentially to accelerate time-to-market. The firm also operates MediLife Digital Health, providing SaMD regulatory and quality services supported by its proprietary Vera compliance intelligence platform.

Product overview

MediLife operates as a MedTech commercialisation consultancy with two main components: proprietary technology platforms and partner product portfolio. The core offering combines commercial consultancy, clinical research, and sales team deployment services. MediLife's proprietary Vera platform provides compliance intelligence for digital health products. The partner product portfolio includes medical imaging technologies (nu:view breast CT, SwiftMR AI-MRI, ClariCT.AI, Mammoscape), respiratory devices (Easy Squeezy), and interventional tools (Biopsy Needles). YOUTILIX, a co-founded subsidiary, provides specialist radiology AI deployment services across DACH, UK and beyond. Services span market entry strategy, NHS access, clinical trial management, marketing, and sales team deployment across UK and Europe.

Differentiator

Problem solved

Functional benefit

Brands

• MediLife Digital Health: Digital health regulatory services including SaMD consultancy, IEC 62304, ISO 13485 compliance, and the Vera compliance intelligence platform.
• YOUTILIX
• Vera

Products and services

• Clinical Research Services End-to-end clinical research organisation (CRO) services including clinical study design and management, real-world evidence generation, KOL engagement, site selection, and regulatory submission support for MedTech companies entering UK and European markets.
• Commercial Consultancy Strategic market entry and commercialisation advisory including market access and reimbursement strategy, go-to-market planning, NHS and private hospital access, KOL engagement, partnership development, product development advisory, and pricing/commercial model design for MedTech companies.
• Sales Team Deployment Provision of dedicated brand representatives (Key Account Managers, country managers, and marketing leads) who are employed and managed by MediLife but represent client brands across NHS trusts, private hospitals, and integrated care systems to drive clinical engagement and sales in European markets.
• Marketing and Value Communications Strategic marketing, brand strategy and positioning, value proposition development, digital marketing and content, medical communications, PR, and congress and event management services designed to articulate clinical and economic benefits to healthcare decision-makers.
• Digital Health Regulatory Services Regulatory, quality, and software engineering services for Software as a Medical Device (SaMD) and medical device software, covering IEC 62304, ISO 13485, MDR/IVDR alignment, and submission support, delivered through the MediLife Digital Health sub-brand.
• Vera Compliance Intelligence Platform Proprietary compliance intelligence platform that applies a deterministic review methodology to identify regulatory gaps, assess objective evidence, and improve submission readiness for digital health and SaMD products.

Quantifiable outcome

• UK market introduction completed successfully with strong clinical adoption in key accounts
• +3 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• YOUTILIXcoreStrategic or Co-development PartnerYOUTILIX is a radiology-focused AI commercial consultancy venture co-founded by MediLife CEO Ian Galloway. Headquartered in Germany with UK subsidiary, it provides specialist deployment services for radiology AI products across DACH region, UK and beyond. MediLife leadership (Paul Rowe and Ian Galloway) hold leadership positions at YOUTILIX ensuring strategic alignment.
• National Breast Imaging AcademycoreStrategic or Co-development PartnerEstablished relationship with National Breast Imaging Academy for breast health market access and clinical network development in UK market.
• Franklyn HealthminorStrategic or Co-development PartnerCollaborative partnership for joint webinar on clinical study design for MedTech innovators. Franklyn Health brings regulatory and HTA expertise to complement MediLife's commercial capabilities.
• NHS TrustscoreChannel Partner/ Reseller/ DistributorMultiple NHS trusts engaged for clinical trials, product evaluations, and commercial adoption of MedTech client products. Trusts include University Hospitals Bristol and Weston among others shown in logo display.
• German GPOs (Group Purchasing Organisations)minorChannel Partner/ Reseller/ DistributorInsight into how German Group Purchasing Organisations make purchasing decisions supports client market access strategy in Germany.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Premier Research: Premier Research is a clinical research services provider with medical device and specialty drug trial capabilities, including European operations. Comparable to MediLife on the CRO side of the service stack.
• IQVIA: IQVIA is a global life sciences services giant offering CRO, real-world evidence, market access, and commercial services across pharma and MedTech. It competes with MediLife for European commercialization mandates but as a broad incumbent rather than MedTech specialist.
• Medpace: Medpace is a mid-to-large CRO with growing MedTech and device trial capabilities and European clinical operations. It overlaps MediLife's clinical research and regulatory service line but operates at significantly greater scale.
• ICON plc: ICON is a global CRO with broad MedTech clinical research capabilities, including European market access support. It is a much larger incumbent with overlapping but broader service offerings compared with MediLife's boutique positioning.

Direct peers

• NAMSA: NAMSA is a medical device-focused CRO and regulatory/quality consulting firm that helps MedTech companies with clinical research, regulatory submissions, and market access. It is the closest direct peer to MediLife in medical device commercialization services, though much larger in scale.
• PharmaLex (now Cencora PharmaLex): PharmaLex (merged into Cencora's PharmaLex) provides regulatory affairs, clinical development, and market access consulting across pharma and MedTech, including digital health. Its regulatory and market access services overlap MediLife Digital Health's SaMD compliance work.
• Alira Health: Alira Health is a MedTech and pharma advisory that combines clinical research, regulatory strategy, market access, and commercial services — the same integrated commercial-plus-clinical positioning MediLife uses, making it a direct peer in European MedTech commercialization.
• Bridgehead International: Bridgehead International is a UK/Europe-based consultancy dedicated to MedTech market access, reimbursement, and commercialization. Its service mix and European footprint overlap closely with MediLife's commercial consultancy offering.

Emerging players

• Sagentia: Sagentia is a UK-based MedTech innovation and product development consultancy. It overlaps MediLife's commercial and clinical advisory work, with adjacent services in early product strategy rather than late-stage market access.

Others

• Covington & Burling (EU MedTech practice): Covington & Burling is an international law firm with a substantial EU/UK MedTech regulatory and reimbursement practice. It competes for regulatory pathway mandates that overlap MediLife's regulatory services, but as an enabling legal advisor rather than commercial consultancy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/med-i-life

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediLife